Registry of overweight and obese adults with type 1 diabetes
Prevalence of Overweight and Obesity in Adult Patients Suffering From Type 1 Diabetes and Its Effect on Treatment and Associated Co-morbidities
This study is creating a registry of overweight and obese adults with type 1 diabetes to see how their weight affects their diabetes management and health outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100000 (estimated) |
| Sex | All |
| Sponsor | Universitaire Ziekenhuizen KU Leuven Academic / other |
| Locations | 1 site (Leuven) |
| Trial ID | NCT05713448 on ClinicalTrials.gov |
What this trial studies
This observational study establishes a registry of adult patients with type 1 diabetes who visit the Department of Endocrinology at the University Hospitals of Leuven. The aim is to phenotype these patients, focusing on their obesity and treatment responses. Data collected will include sociodemographics, medical history, glycemic control, comorbidities, clinical and anthropometric parameters, and lifestyle factors. This comprehensive database will help in understanding the impact of obesity on type 1 diabetes outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults diagnosed with type 1 diabetes who are also experiencing overweight or obesity.
Not a fit: Patients who do not have type 1 diabetes or those who are not overweight or obese may not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could lead to improved management strategies for overweight and obese patients with type 1 diabetes.
How similar studies have performed: While there have been studies on obesity in type 2 diabetes, this specific focus on type 1 diabetes and obesity is less common, indicating a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Signed informed consent * Type 1 Diabetes
Where this trial is running
Leuven
- Departement Endocrinology, University Hospitals Leuven — Leuven, Belgium (Recruiting)
Study contacts
- Study coordinator: Bart Van der Schueren, MD, PhD
- Email: bart.vanderschueren@uzleuven.be
- Phone: +3216346994
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.